CN3936165
Active
Amendment A2
Imported Plasma and Recombinant Products
$169.5M
Contract Value
Contract Details
- Contract ID
- CN3936165
- Status
- active
- Financial Year
- FY26
- Category
- Healthcare Services(UNSPSC: 85100000)
Key Dates
- Publish Date
- 15 Feb 2026
- Signed Date
- 9 Feb 2023
- Start Date
- 31 Dec 2022
- End Date
- 29 June 2027
- Duration
- 4 years, 7 months
Procurement Information
- Procurement Method
- Limited tender
- Exemption Code
- TR
- Exemption Reason
- 10.3.d.iii. Supply by particular business: due to an absence of competition for technical reasons.
Contract History
This contract has been amended 2 times. Currently showing amendment A2.
Original Contract
Published 9 Feb 2023 · 31 Dec 2022 to 29 June 2027
$80.3M
Amendment A1
Published 15 Feb 2026 · 31 Dec 2022 to 29 June 2027
$115.5M
+$35.2M
Amendment A2
Current
Published 15 Feb 2026 · 31 Dec 2022 to 29 June 2027
$169.5M
+$54.0M
Supplier
NOVO NORDISK PHARMACEUTICALS PTY. LIMITED
- ABN
- 40 002 879 996
- Entity Type
- Australian Private Company
- Location
- NSW